Program areas at St Jude Children's Research Hospital
Research: the current basic science and clinical Research at the Hospital includes work in gene therapy, chemotherapy, the biochemistry of normal and cancerous cells, radiation treatment, blood diseases, resistance to therapy, viruses, neurological diseases, hereditary diseases, influenza, pediatric aids and physiological effects of catastrophic illnesses.
Education and training: as part of its mission, the Hospital has developed a global initiative (St. Jude global) to improve the survival rates of children with cancer and other catastrophic diseases worldwide. St. Jude global accomplishes this by sharing knowledge, technology and organizational skills, helping to implement new approaches to treat pediatric cancer globally, and developing regional networks committed to eradicating cancer in children. This mission will be achieved by focusing on three overriding goals: (1) to train the clinical workforce that will be required to meet our mission, (2) to develop and strengthen health systems and patient-centered initiatives that encompass the entire continuum of care required for children with cancer and non-malignant hematological (continued on schedule o) diseases, and (3) to advance knowledge in global pediatric oncology and hematology through Research to sustain a continuous improvement in the level and quality of care delivered around the globe. These initiatives are spearheaded by St. Jude experts who work closely with healthcare professionals at our partner sites. In addition, graduate programs at both the doctoral and master's levels are offered through a wholly owned subsidiary, St. Jude Children's Research Hospital graduate school of biomedical sciences, llc, to educate and train future generations of biomedical researchers and medical professionals seeking to probe the molecular basis of disease, develop therapies and advance global health for children with pediatric catastrophic diseases.
Patient care: the Hospital provided 18,555 inpatient days of care during the year. Our bone marrow transplantation program accounted for 4,463 or 24% of those inpatient days. Patients made 77,186 clinic registrations during the year.